{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:16:57Z","timestamp":1773922617621,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ijantimicag.2014.01.029","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T20:54:29Z","timestamp":1395435269000},"page":"540-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacodynamic profiling of modithromycin: Assessment in a pneumococcal murine pneumonia model"],"prefix":"10.1016","volume":"43","author":[{"given":"Dana","family":"Maglio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather K.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toral","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Anne","family":"Banevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ly T.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0005","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.01469-10","article-title":"In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci","volume":"55","author":"Sato","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0010","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Document M100-S23","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/AAC.41.2.345","article-title":"Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the post-antibiotic effect of imipenem","volume":"41","author":"Joly-Guillou","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0020","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/jac\/dkr161","article-title":"In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae","volume":"66","author":"Sato","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2014.01.029_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1469-0691.2001.00051.x","article-title":"Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin","volume":"7","author":"Drusano","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0030","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.46.10.3185-3192.2002","article-title":"Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0035","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1128\/AAC.00024-11","article-title":"In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-\u03b2-lactamase (ESBL)-producing and non-ESBL-producing Enterobacteriaceae","volume":"55","author":"Wiskirchen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0924-8579(03)00156-0","article-title":"Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia model","volume":"22","author":"Capitano","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijantimicag.2005.02.014","article-title":"Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model","volume":"25","author":"Dandekar","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0050","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/AAC.00567-09","article-title":"Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects","volume":"54","author":"Furuie","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.029_bib0055","series-title":"47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"The efficacy, the safety and pharmacokinetics (PK) of S-013420, a bicyclolide in patients with community-acquired pneumonia (CAP)","author":"Kohno","year":"2007"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:53:19Z","timestamp":1565293999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0924857914000582"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.029","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic profiling of modithromycin: Assessment in a pneumococcal murine pneumonia model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}